오리엔트바이오

002630KOSPI

54.8 / 100

Reference Date: 2026-09-08

Financial Score18.5 / 40

News Sentiment18.3 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 14.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Orient Bio operates in the biotechnology infrastructure sector, specializing in SPF egg production, CRO clinical trial services, and the development of bio-experimental equipment and biological materials, while adhering to international standards such as ICH, GLP, and GMP. The biotechnology industry, characterized by high added value and growth potential, is a key focus area for the company, contributing to healthcare, research, and pharmaceutical sectors.

Number of Employees

123people

Average Salary

32.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.75Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

-16.82Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

12.14Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.1% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼260.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -0.2% (declining, 2yr)

Detailed News Sentiment

3 totalPositive 2Neutral 1Negative 0Average Sentiment Score 73.3

Neutral
영장류 CRO 띄우는 오리엔트바이오…핵심 역량 질문엔 ‘모르쇠’
Orient Biotechnology's CRO capabilities for primate non-clinical trials are questioned, leading to uncertainty without direct impact on stock performance.
Positive
오리엔트바이오, 1분기 영업익 흑자전환…비용구조 개선 효과
오리엔트바이오의 1분기 영업이익 흑자 전환으로 인해 실적 개선이 확인되었다.
Positive
오리엔트, 오리엔트바이오 주식 300만주 장내 매수…책임경영 강화
오리엔트그룹의 오리엔트바이오 주식 장내 매수로 책임경영 강화와 주주가치 향상 기대.

Detailed Momentum

52-week position6.0Point

52w upper range (73%)

Current 913Won52-week high 1,07052-week low 467

1-month return1.0Point

1m -14.27% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-09-04
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-09-04
Neutral분기보고서 (2026.06)2026-08-14